Zydus Pharmaceuticals is recalling 2,207 vials of Ethacrynate Sodium for Injection (50mg/vial) because the product was manufactured in a facility with deviations from Current Good Manufacturing Practice (cGMP) standards. While no specific patient injuries or drug defects have been reported, these manufacturing issues can compromise the quality and safety of the medication. Consumers who have these vials should contact their healthcare provider for guidance and return the product to their pharmacy. Ethacrynate Sodium is a prescription diuretic used to treat severe fluid retention (edema) in patients with heart, liver, or kidney issues.
Manufacturing deviations at the facility mean the drug's safety, identity, strength, and purity may not be guaranteed. These quality control failures could potentially lead to inconsistent dosing or the presence of unintended substances, which poses a health risk to patients receiving this injectable medication.
Drug recall baseline remedy
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.